← All trials
NCT00814255
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2008
- Primary completion
- Jun 1, 2013
- Completion date
- Feb 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- New York UniversityLead sponsor
- University of MichiganOverall official - principal investigator
- University of RochesterOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- University of MichiganCollaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- University of RochesterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.